Kite shoots for first CAR-T OK in Europe, staying one step behind Novartis in US race – Endpoints News
Endpoints News |
Kite shoots for first CAR–T OK in Europe, staying one step behind Novartis in US race
Endpoints News The two CAR-Ts have been under intense scrutiny for the past two years as Novartis and the much smaller Kite hustled along personalized cell therapies that take T cells from patients and equips them with chimeric antigen receptors so they can hunt down … |
